Melissa Baird
Hematology & Oncology · Anniston, ALNPI 1730134925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,121 and has fallen 98.7% since, to $14 in 2025. That places this record below the midpoint for hematology & oncology clinicians in AL, where the typical reported total is $7,159.
Across 93 payments — averaging $15.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$172
- Johnson & Johnson$123
- Mckesson Specialty Care Distribution, LLC$117
- Amgen$103
- E.r. Squibb & Sons, L.L.C.$102
- Novartis$94
- plus $705 from 20 others
What the payments were for
- Food & beverage$1,39799%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $172 |
| Johnson & Johnson(2 entities) | 11 | $123 |
| Mckesson Specialty Care Distribution, LLC | 1 | $117 |
| Amgen | 7 | $103 |
| E.r. Squibb & Sons, L.L.C. | 7 | $102 |
| Novartis | 6 | $94 |
| Merck | 6 | $91 |
| Bristol Myers Squibb | 4 | $75 |
| AstraZeneca | 4 | $60 |
| Array Biopharma Inc | 3 | $53 |
| Incyte Corporation | 3 | $49 |
| Exelixis Inc. | 3 | $48 |
| Seagen Inc. | 3 | $43 |
| Eisai Inc. | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $35 |
| Kyowa Kirin, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $27 |
| AbbVie | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| GE HealthCare | 1 | $14 |
| Mylan Institutional Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
| Lilly USA, LLC | 1 | $12 |
How this compares
$1,417 in reported general payments places this provider in the 20th percentile of 177 hematology & oncology providers in Alabama.
Other hematology & oncology in Anniston
- Aasim SehbaiAnniston$30K
- Amitkumar MehtaBirmingham$683K
- Pankit VachhaniBirmingham$545K
- Luciano CostaBirmingham$409K
- Khaleel AshrafBirmingham$379K
- Michael BirrerBirmingham$302K
- Rudolph NavariBirmingham$254K
- Mayur NarkhedeBirmingham$193K
- Midhun MallaBirmingham$144K
- Robert ConryBirmingham$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.